CORAL GABLES, Fla., Feb. 28, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX), a specialty pharmaceutical company focused on developing safe and effective, approved medicines targeting orphan neuromuscular and neurological diseases, joins with the National Organization for Rare Disorders (NORD) in the observance of Rare Disease Day.
Help employers find you! Check out all the jobs and post your resume.
